Inspire Medical Systems Inc
INSP
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.99B
Close$
$154.54
120.4% upside
Current Fair Value
120.4% upsideUndervalued by 120.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.99 Billion |
|---|---|
| Enterprise Value | $1.89 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $4.95 |
| Beta | 0.73 |
| Outstanding Shares | 28,835,058 |
Return
| Return on Equity | 16.36% |
|---|---|
| Return on Assets | 14.58% |
| Return on Invested Capital | 5.76% |
Valuation & Multiples
| P/E Ratio | 14.78 |
|---|---|
| PEG | -13.59 |
| Price to Sales | 2.26 |
| Price to Book Ratio | 2.5 |
| Enterprise Value to Revenue | 2.11 |
| Enterprise Value to EBIT | 38.46 |
| Enterprise Value to Net Income | 14 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 3, 2026
EPS Estimate
$-0.24
Average shareholder expectationRevenue Estimate
$194.72 M
Average shareholder expectationNext Earnings Call
Expected Date
November 2, 2026
EPS Estimate
$0.09
Average shareholder expectationRevenue Estimate
$204.31 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 141.89% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.02%▼ 129.88% |
|---|---|
| Total Invested | $462,320▼ 99.97% |
| Investors Holding | 10▼ 275.00% |
ESG Score
No data
About Inspire Medical Systems Inc
CEO: Timothy Herbert Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the first and onl...